| Revision as of 12:16, 10 December 2011 editEnix150 (talk | contribs)Extended confirmed users8,941 editsmNo edit summary← Previous edit | Revision as of 12:27, 10 December 2011 edit undoCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'CAS_number_Ref') per Chem/Drugbox validation (report [[Misplaced Pages talk:WikiProject_Pharmac...Next edit → | ||
| Line 1: | Line 1: | ||
| {{Drugbox | {{Drugbox | ||
| | verifiedrevid = |
| verifiedrevid = 448189696 | ||
| | IUPAC_name = 8a-phenyldecahydroquinoline | | IUPAC_name = 8a-phenyldecahydroquinoline | ||
| | image = Phenyldecahydroquinoline.svg | | image = Phenyldecahydroquinoline.svg | ||
| Line 15: | Line 15: | ||
| <!--Identifiers--> | <!--Identifiers--> | ||
| | CAS_number_Ref = {{cascite|correct|??}} | |||
| | CAS_number = 131556-11-1 | | CAS_number = 131556-11-1 | ||
| | PubChem = 131397 | | PubChem = 131397 | ||
Revision as of 12:27, 10 December 2011
Pharmaceutical compound | |
| Identifiers | |
|---|---|
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C15H21N |
| Molar mass | 215.3339 g/mol g·mol |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| (verify) | |
8a-Phenyldecahydroquinoline (8A-PDHQ) is a high affinity NMDA antagonist. It is a structural analog of Phencyclidine with slightly lower binding affinity than the parent compound. (-)-8a-Phenyldecahydroquinoline has an in vivo potency comparable to that of (+)-MK-801.
References
- Chen C, Kozikowski AP, Wood PL, Reynolds IJ, Ball RG, Pang YP (1992). "Synthesis and biological activity of 8a-phenyldecahydroquinolines as probes of PCP's binding conformation. A new PCP-like compound with increased in vivo potency". J Med Chem. 35 (9): 1634–8. doi:10.1021/jm00087a020. PMID 1315871.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - Elhallaoui M, Laguerre M, Carpy A, Ouazzani FC (2002). "Molecular modeling of noncompetitive antagonists of the NMDA receptor: proposal of a pharmacophore and a description of the interaction mode". J Mol Model. 8 (2): 65–72. doi:10.1007/s00894-001-0067-4. PMID 12032600.
{{cite journal}}: CS1 maint: multiple names: authors list (link)
| Glutamate receptor modulators | |||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||||||||||||||||||||||||
 | This hallucinogen-related article is a stub. You can help Misplaced Pages by expanding it. |